L. Cicinsain et B. Jernej, REDUCTION OF GASTROINTESTINAL SEROTONIN IN ALLOXAN-DIABETIC RATS - REVERSAL BY 5-HYDROXYTRYPTOPHAN TREATMENT, Behavioural brain research, 73(1-2), 1995, pp. 285-288
A rat model of alloxan-induced diabetes was used to investigate the ef
fect of diabetic state on serotonin (5-HT) levels in peripheral body c
ompartments, gastrointestinal (GI) and platelet, and the metabolic res
ponse of these compartments to serotonin precursor (5-hydroxytryptopha
n, 5-HTP) loading in diabetes. In all segments of diabetic gut a massi
ve reduction in 5-HT concentration (to 45-64% at 6th week after induct
ion of diabetes, with further progression to 30-52% at 14th week) was
shown. After parenteral loading with 5-HTP for 6 days (30 mg/kg per da
y) 5-HT concentration in all parts of the GI tract returned to the con
trol values (82-108%), indicating reduced serotonin precursor availabi
lity in diabetes. Platelet serotonin levels (PSL) in diabetic rats dem
onstrated a slight gradual reduction that became significant at 14th w
eek of diabetic state. On the mentioned 5-HTP challenge only blunted r
esponse of PSL in diabetics, as contrasted to control animals (54% vs.
113%) was shown, indicating possible suppression of the membrane 5-HT
transporter. The observed alterations in peripheral 5-HT homeostasis
in diabetic rats as well as the possibility of their reversal by 5-HTP
treatment could be of clinical interest.